Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
AgeChem Venture Fund
About
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting
- Montréal,Quebec,Canada
- http://genechem.com/agechem.php
Details
- Founded date
- Jan 1, 2006
- Operating Status
- Active
- Investor Type
- Venture Capital
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 15, 2014
Sorbent Therapeutics
|
Series D | $6.50M | Biopharma | — |
|
Nov 6, 2013
Aerpio Pharmaceuticals
|
Series A | $36M | Biotechnology | — |
|
Jun 4, 2013
Akebia Therapeutics
|
Series C | $41M | Biotechnology | — |
|
Nov 2, 2012
Alethia BioTherapeutics
|
Series B | $4.70M | Biotechnology | — |
|
Sep 27, 2011
Medicago
|
Post-IPO Equity | $25M | Biotechnology | — |
Employee Profiles
Exits
AgeChem Venture Fund has had 5 exits. AgeChem Venture Fund most notable exits include Aerpio Pharmaceuticals , Akebia Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Feb 2, 2018 | Aerpio Pharmaceuticals | IPO | Biotechnology | Detail |
| Mar 20, 2014 | Akebia Therapeutics | IPO | Biotechnology | Detail |
| Jul 25, 2013 | Conatus Pharmaceuticals | M&A | Biotechnology | Detail |
| Apr 4, 2011 | Ocera Therapeutics | M&A | Biopharma | Detail |
| Aug 30, 2006 | Medicago | M&A | Biotechnology | Detail |
